GB201102237D0 - Particle formulation - Google Patents

Particle formulation

Info

Publication number
GB201102237D0
GB201102237D0 GBGB1102237.3A GB201102237A GB201102237D0 GB 201102237 D0 GB201102237 D0 GB 201102237D0 GB 201102237 A GB201102237 A GB 201102237A GB 201102237 D0 GB201102237 D0 GB 201102237D0
Authority
GB
United Kingdom
Prior art keywords
particle formulation
formulation
particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1102237.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LENA NANOCEUTICS Ltd
Kuecept Ltd
Original Assignee
LENA NANOCEUTICS Ltd
Kuecept Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LENA NANOCEUTICS Ltd, Kuecept Ltd filed Critical LENA NANOCEUTICS Ltd
Priority to GBGB1102237.3A priority Critical patent/GB201102237D0/en
Publication of GB201102237D0 publication Critical patent/GB201102237D0/en
Priority to PCT/GB2012/050283 priority patent/WO2012107765A2/en
Ceased legal-status Critical Current

Links

GBGB1102237.3A 2011-02-09 2011-02-09 Particle formulation Ceased GB201102237D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1102237.3A GB201102237D0 (en) 2011-02-09 2011-02-09 Particle formulation
PCT/GB2012/050283 WO2012107765A2 (en) 2011-02-09 2012-02-09 Particle formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1102237.3A GB201102237D0 (en) 2011-02-09 2011-02-09 Particle formulation

Publications (1)

Publication Number Publication Date
GB201102237D0 true GB201102237D0 (en) 2011-03-23

Family

ID=43836446

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1102237.3A Ceased GB201102237D0 (en) 2011-02-09 2011-02-09 Particle formulation

Country Status (2)

Country Link
GB (1) GB201102237D0 (en)
WO (1) WO2012107765A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
CN107880091B (en) 2012-05-08 2020-12-18 尼科斯眼药公司 Formulations of hydrophobic therapeutic agents, methods of making and uses thereof
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
CA2910766C (en) 2013-04-30 2020-12-15 Otitopic Inc. Dry powder formulations and methods of use
US9993488B2 (en) 2014-02-20 2018-06-12 Otitopic Inc. Dry powder formulations for inhalation
AU2015296142A1 (en) * 2014-07-31 2017-02-23 Otitopic Inc. Dry powder formulations for inhalation
US10517828B2 (en) * 2014-10-08 2019-12-31 Zambon S.P.A. Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
DE102016218604A1 (en) 2016-09-27 2018-03-29 Constantin Adams A particulate mixture, preferably for use in the prophylaxis and / or treatment of an airway disorder
WO2019059953A2 (en) 2017-09-22 2019-03-28 Otitopic Inc. Dry powder compositions with magnesium stearate
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
WO2021216710A1 (en) * 2020-04-24 2021-10-28 The Medical College Of Wisconsin, Inc. Use of salmeterol as an anti-coronaviral agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3732508B2 (en) 1993-10-01 2006-01-05 アストラ・アクチエボラーグ Method for producing powdered drug
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
FI20002215A0 (en) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Combination Particles
US7572430B2 (en) 2000-11-09 2009-08-11 Cyprus Amax Minerals Company Method for producing nano-particles
GB0516549D0 (en) 2005-08-12 2005-09-21 Sulaiman Brian Milling system
EA015999B1 (en) 2006-10-24 2012-01-30 Бенек Ой Device for producing nanoparticles
EP2050437A1 (en) * 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.

Also Published As

Publication number Publication date
WO2012107765A3 (en) 2012-11-15
WO2012107765A2 (en) 2012-08-16

Similar Documents

Publication Publication Date Title
ZA201306391B (en) Nanoparticle compositions
GB201111438D0 (en) Formulation
GB201102237D0 (en) Particle formulation
HK1211862A1 (en) Nanoparticle formulation
ZA201309221B (en) Formulation
EP2699670A4 (en) Cell-synthesized particles
EP2755020A4 (en) Particle detector
HK1202445A1 (en) New formulation
PL2380962T3 (en) Particle
PL2701506T3 (en) Formulation component
GB201111775D0 (en) Compounds and uses thereof
EP2867303A4 (en) Silsesquioxane-like particles
ZA201402456B (en) Formulation
GB201121377D0 (en) Formulation component
HK1201685A1 (en) Pazopanib formulation
IL229106A (en) Encapsulated particle
PL2584028T3 (en) Particle
GB201107039D0 (en) Formulation component
HUE037814T2 (en) Formulation component
GB201110278D0 (en) Formulations
HK1208689A1 (en) Particle size reduction
GB201106958D0 (en) Formulation
GB2496656B (en) Film-Forming Formulation
GB201104284D0 (en) Formulation
ZA201308107B (en) Spread

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)